Approved Ligands

Apixaban is a highly selective, reversible inhibitor of Factor Xa with Ki of 0.08 nM and 0.17 nM in human and rabbit, respectively. Apixaban is in development for the prevention and treatment of various thromboembolic diseases.

Apixaban is a highly selective, reversible inhibitor of Factor Xa with Ki of 0.08 nM and 0.17 nM in human and rabbit, respectively. Apixaban is in development for the prevention and treatment of various thromboembolic diseases.

Apixaban is a highly selective, reversible inhibitor of Factor Xa with Ki of 0.08 nM and 0.17 nM in human and rabbit, respectively. Apixaban is in development for the prevention and treatment of various thromboembolic diseases.

Apremilast (CC-10004) is a potent and orally active PDE4 and TNF-α inhibitor with IC50 of 74 nM and 77 nM, respectively.Apremilast(CC10004)是PDE4抑制剂，IC50为74 nM。.

Apremilast (CC-10004) is a potent and orally active PDE4 and TNF-α inhibitor with IC50 of 74 nM and 77 nM, respectively.Apremilast(CC10004)是PDE4抑制剂，IC50为74 nM。.

Apremilast (CC-10004) is a potent and orally active PDE4 and TNF-α inhibitor with IC50 of 74 nM and 77 nM, respectively.Apremilast(CC10004)是PDE4抑制剂，IC50为74 nM。.

Apremilast (CC-10004) is a potent and orally active PDE4 and TNF-α inhibitor with IC50 of 74 nM and 77 nM, respectively.Apremilast(CC10004)是PDE4抑制剂，IC50为74 nM。.

Aprepitant is a potent and selective neurokinin-1 receptor antagonist.

Aprepitant is a potent and selective neurokinin-1 receptor antagonist.

Aprepitant is a potent and selective neurokinin-1 receptor antagonist.

Aprepitant is a potent and selective neurokinin-1 receptor antagonist.

Aprepitant is a potent and selective neurokinin-1 receptor antagonist.